Impact of COVID-19 outbreak on the care of patients with inflammatory bowel disease: a comparison before and after the outbreak in South China.

Zhang, Ying-Fan, Qiu, Yun, He, Jin-Shen, Tan, Jin-Yu, Li, Xiao-Zhi, Zhu, Liang-Ru, Chen, Yan, Liu, Zhan-Ju, Iacucci, Marietta, Chen, Bai-Li, He, Yao, Ben-Horin, Shomron, Shen, Bo, Zeng, Zhi-Rong, Ghosh, Subrata, Chen, Min-Hu and Mao, Ren (2020) Impact of COVID-19 outbreak on the care of patients with inflammatory bowel disease: a comparison before and after the outbreak in South China. Journal of gastroenterology and hepatology. ISSN 1440-1746. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/

Abstract

BACKGROUND AND AIMS

Epidemics pose a great challenge to health care of patients. However, the impact of unprecedented situation of COVID-19 outbreak on healthcare of inflammatory bowel disease (IBD) patients in real-world setting has seldom been investigated.

METHODS

We performed an observational study in a tertiary referral IBD center in China. The mode of healthcare and medication use was compared before and after COVID-19 outbreak. Electronic questionnaire surveys were performed amongst gastroenterologists and IBD patients to investigate impact of COVID-19 outbreak on their attitudes towards telemedicine.

RESULTS

COVID-19 outbreak resulted in substantial decrease of patients participating in standard face-to-face visit during one month post-outbreak (n=51) than pre-outbreak (n=249), whereas the participation in telemedicine was significantly higher than comparable period in 2019 (414 vs 93). During the one month after COVID-19 outbreak, 39 (39/56, 69.6%) patients had their infliximab infusion postponed with the mean delay of 3 weeks. The immunomodulator use was similar between pre- and post-outbreak. Six elective surgeries were postponed for a median of 43 days. In post-outbreak period, 193 (193/297, 64.98%) of the surveyed physicians have used telemedicine with an increase of 18.9% compared to 46.13% (137/292) in the pre-outbreak period (p<0.001). 331(331/505, 65.54%) of the surveyed IBD patients supported that use of telemedicine should be increased in future healthcare.

CONCLUSION

COVID-19 outbreak resulted in a great change in health care access among IBD patients including decrease in standard face-to-face visit and delay of biologics use. There was an increased use and need of telemedicine after COVID-19 outbreak.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: WA Patients. Primary care. Medical profession. Forensic medicine
WC Communicabable diseases
WE Musculoskeletal. Orthopaedics
WI Digestive system. Gastroenterology
Divisions: Planned IP Care > Gastroentrology
Related URLs:
Depositing User: Jamie Edgar
Date Deposited: 07 Aug 2020 14:56
Last Modified: 07 Aug 2020 14:56
URI: http://www.repository.uhblibrary.co.uk/id/eprint/3349

Actions (login required)

View Item View Item